Chronic exercise leads to antiaggregant, antioxidant and anti-inflammatory effects in heart failure patients

European Journal of Preventive Cardiology

Volumn 21, Issue 10, 2014, Pages 1225-1232

  Meirelles, Luisa Ribeiro De ^a   Matsuura, Cristiane ^a   Resende, Angela De Castro ^a   Salgado, Ângelo Antunes ^a   Pereira, Natália Rodrigues ^a   Coscarelli, Pedro Guimaraes ^a   Mendes Ribeiro, Antônio C ^a,b   Brunini, Tatiana M C ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

Author keywords

Blood platelets; exercise therapy; nitric oxide

Indexed keywords

ADENOSINE DIPHOSPHATE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CATALASE; COLLAGEN; CYCLIC GMP; FIBRINOGEN; INTERLEUKIN 6; NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; AUTACOID; LIPID;

ANTHROPOMETRIC PARAMETERS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR RISK; CHRONIC EXERCISE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXERCISE; HEART FAILURE; HUMAN; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; RISK ASSESSMENT; SEDENTARY LIFESTYLE; STRETCHING EXERCISE; THROMBOCYTE AGGREGATION INHIBITION; TREADMILL EXERCISE; BLOOD; BLOOD CLOTTING PARAMETERS; BRAZIL; CONVALESCENCE; ENZYMOLOGY; FEMALE; IMMUNOLOGY; INFLAMMATION; KINESIOTHERAPY; MALE; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; OXYGEN CONSUMPTION; PREDICTIVE VALUE; PROCEDURES; PROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOSIS; TIME; TREATMENT OUTCOME;

ANTIOXIDANTS; BIOLOGICAL MARKERS; BLOOD PLATELETS; BRAZIL; CYCLIC GMP; EXERCISE THERAPY; FEMALE; HEART FAILURE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPIDS; MALE; MIDDLE AGED; MOTOR ACTIVITY; MUSCLE STRETCHING EXERCISES; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; RESISTANCE TRAINING; RISK FACTORS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84907512342     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487313491662     Document Type: Article

References (29)

1. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012 ; 33: 1787-1847
2. Witt BJ, Gami AS, Ballman KV, et al. The incidence of ischemic stroke in chronic heart failure: a meta-analysis. J Card Fail. 2007 ; 13: 489-496
3. Jafri SM, Ozawa T, Mammen E, et al. Platelet function, thrombin and fibrinolytic activity in patients with heart failure. Eur Heart J. 1993 ; 14: 205-212
4. Gibbs CR, Blann AD, Watson RD, et al. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy. Circulation. 2001 ; 103: 1746-1751
5. de Meirelles LR, Resende AC, Matsuura C, et al. Platelet activation, oxidative stress and overexpression of inducible nitric oxide synthase in moderate heart failure. Clin Exp Pharmacol Physiol. 2011 ; 38: 705-710
6. Chen LY, Mehta JL. Further evidence of the presence of constitutive and inducible nitric oxide synthase isoforms in human platelets. J Cardiovasc Pharmacol. 1996 ; 27: 154-158
7. Gegenbauer K, Elia G, Blanco-Fernandez A, et al. Regulator of G-protein signaling 18 integrates activating and inhibitory signaling in platelets. Blood. 2012 ; 119: 3799-3807
8. Gryglewski RJ, Palmer RM, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986 ; 320: 454-456
9. Radovanovic S, Savic-Radojevic A, Pljesa-Ercegovac M, et al. Markers of oxidative damage and antioxidant enzyme activities as predictors of morbidity and mortality in patients with chronic heart failure. J Card Fail. 2012 ; 18: 493-501
10. Shah A, Passacquale G, Gkaliagkousi E, et al. Platelet nitric oxide signalling in heart failure: role of oxidative stress. Cardiovasc Res. 2011 ; 91: 625-631
11. Maron BA, Tang SS, Loscalzo J. S-nitrosothiols and the S-nitrosoproteome of the cardiovascular system. Antioxid Redox Signal. 2013 ; 18: 270-287
12. Morrell CN, Matsushita K, Chiles K, et al. Regulation of platelet granule exocytosis by S-nitrosylation. Proc Natl Acad Sci USA. 2005 ; 102: 3782-3787
13. Irwin C, Roberts W, Naseem KM. Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: the potential role for S-nitrosylation. Platelets. 2009 ; 20: 478-486
14. Antunes-Correa LM, Kanamura BY, Melo RC, et al. Exercise training improves neurovascular control and functional capacity in heart failure patients regardless of age. Eur J Prev Cardiol. 2012 ; 19: 822-829
15. Downing J, Balady GJ. The role of exercise training in heart failure. J Am Coll Cardiol. 2011 ; 58: 561-569
16. Beaver WL, Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol. 1986 ; 60: 2020-2027
17. Mezzani A, Hamm LF, Jones AM, et al. Aerobic exercise intensity assessment and prescription in cardiac rehabilitation: a joint position statement of the European Association for Cardiovascular Prevention and Rehabilitation, the American Association of Cardiovascular and Pulmonary Rehabilitation and the Canadian Association of Cardiac Rehabilitation. Eur J Prev Cardiol. 2012 ;:
18. Zannad F, Stough WG, Regnault V, et al. Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges. Int J Cardiol. 2013 ;:
19. Cleland JG, Mumtaz S, Cecchini L. Role of antithrombotic agents in heart failure. Curr Cardiol Rep. 2012 ; 14: 314-325
20. Dagenais GR, Pogue J, Fox K, et al. Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials. Lancet. 2006 ; 368: 581-588
21. Gullestad L, Ueland T, Vinge LE, et al. Inflammatory cytokines in heart failure: mediators and markers. Cardiology. 2012 ; 122: 23-35
22. Soskic SS, Dobutovic BD, Sudar EM, et al. Regulation of inducible nitric oxide synthase (iNOS) and its potential role in insulin resistance, diabetes and heart failure. Open Cardiovasc Med J. 2011 ; 5: 153-163
23. Levi M, van der Poll T, Buller HR. Bidirectional relation between inflammation and coagulation. Circulation. 2004 ; 109: 2698-2704
24. Yndestad A, Damas JK, Oie E, et al. Systemic inflammation in heart failure-the whys and wherefores. Heart Fail Rev. 2006 ; 11: 83-92
25. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest. 2005 ; 115: 3378-3384
26. Bombeli T, Schwartz BR, Harlan JM. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med. 1998 ; 187: 329-339
27. Pignatelli P, De Biase L, Lenti L, et al. Tumor necrosis factor-alpha as trigger of platelet activation in patients with heart failure. Blood. 2005 ; 106: 1992-1994
28. De Biase L, Pignatelli P, Lenti L, et al. Enhanced TNF alpha and oxidative stress in patients with heart failure: effect of TNF alpha on platelet O2- production. Thromb Haemost. 2003 ; 90: 317-325
29. Smart NA, Steele M. The effect of physical training on systemic proinflammatory cytokine expression in heart failure patients: a systematic review. Congest Heart Fail. 2011 ; 17: 110-114